Establishment Labs Announces Two-Year Mia Femtech Clinical Results And The Launch Of Zen At 8th World Symposium On Ergonomic Implants
Portfolio Pulse from Benzinga Newsdesk
Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced the two-year clinical results of Mia Femtech and the launch of Zen, its next-generation RFID technology, at the 8th Annual World Symposium on Ergonomic Implants. The Mia Feasibility Clinical Study reported no instances of capsular contracture or rupture in a 100-patient study. The new Zen technology, part of the Zensor RFID platform, is non-ferromagnetic and has the potential to measure temperature and other parameters.
October 13, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Establishment Labs' announcement of successful clinical results and the launch of a new technology could potentially boost investor confidence and the company's stock price.
Positive clinical results and the introduction of new technologies are typically seen as positive indicators of a company's growth and innovation potential. This could lead to increased investor interest and a potential rise in the company's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100